ID
15354
Description
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany
Link
https://clinicaltrials.gov/ct2/show/NCT02419378
Keywords
Versions (3)
- 8/13/15 8/13/15 - Martin Dugas
- 5/23/16 5/23/16 -
- 5/28/16 5/28/16 -
Uploaded on
May 28, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Discontinue Trial Medication Multiple Sclerosis ALAIN01 NCT02419378
Discontinue Trial Medication Multiple Sclerosis ALAIN01 NCT02419378
Similar models
Discontinue Trial Medication Multiple Sclerosis ALAIN01 NCT02419378
C0457454 (UMLS CUI-2)
C0806020 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])